Research Article
High Expression of JMJD4 Is a Potential Diagnostic and Prognostic Marker of Renal Cell Carcinoma
Table 3
Logistic regression analysis of the association between JMJD4 expression and clinical characteristics.
| Characteristics | Total () | Odds ratio(OR) | value |
| T stage (T3 & T4 vs. T1 & T2) | 539 | 1.378 (0.967-1.967) | 0.077 | N stage (N1 vs. N0) | 257 | 2.159 (0.776-6.522) | 0.148 | M stage (M1 vs. M0) | 506 | 1.876 (1.151-3.102) | 0.013 | Gender (male vs. female) | 539 | 0.573 (0.399-0.819) | 0.002 | Age (>60 vs. ≤60) | 539 | 1.336 (0.953-1.876) | 0.093 | Histologic grade (G3 & G4 vs. G1 & G2) | 531 | 1.224 (0.870-1.723) | 0.246 | Race (Black or African American & White vs. Asian) | 532 | 1.679 (0.408-8.255) | 0.481 | Primary therapy outcome (PR & CR vs. PD & SD) | 147 | 0.917 (0.325-2.541) | 0.866 | Pathologic stage (stage III & stage IV vs. stage I & stage II) | 536 | 1.487 (1.048-2.113) | 0.027 |
|
|